Medicine and Dentistry
Non Small Cell Lung Cancer
71%
Metastatic Carcinoma
42%
Chemokine Receptor CCR2 Antagonist
42%
Assay
42%
Malignant Neoplasm
28%
Combination Therapy
28%
Gelatinase B
28%
Chemokine
28%
Patient
28%
Wound Healing
14%
Cancer Cell
14%
Matrigel
14%
Cell Invasion
14%
Lung Cancer
14%
Diagnosis
14%
Cancer Growth
14%
Drug Resistance
14%
Cell Viability
14%
Neutralizing Antibody
14%
Cell Motility
14%
Development
14%
Cell Viability Assay
14%
Cancer Therapy
14%
Matrix Metalloproteinase
14%
Drug
14%
Chemotherapeutic Agent
14%
Lung Adenocarcinoma
14%
Cancer Model
14%
Cells
14%
Therapeutic Procedure
14%
Immunology and Microbiology
CCR2
100%
Lung
100%
Cells
85%
CCL2
42%
Cancer Cell
28%
Chemokine
28%
Cell Viability
28%
Wound Healing Assay
28%
Drug Resistance
14%
Neutralizing Antibody
14%
Cell Invasion
14%
Electric Potential
14%
Development
14%
Cell Motility
14%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
71%
Metastasis
42%
Antagonist
42%
Chemokine Receptor CCR2 Antagonist
42%
Malignant Neoplasm
28%
Gelatinase B
28%
Lung Cancer
14%
Neutralizing Antibody
14%
Matrigel
14%
Drug Resistance
14%
Prognosis
14%
Cancer Growth
14%
Matrix Metalloproteinase
14%
Drug
14%
Cancer Model
14%
Wound Healing
14%
Lung Adenocarcinoma
14%
Biochemistry, Genetics and Molecular Biology
CCR2
100%
CCL2
42%
Matrix Metalloproteinase
42%
Cancer Cell
28%
Chemokine
28%
Cell Viability
28%
Wound Healing Assay
28%
Electric Potential
14%
Development
14%
Neutralizing Antibody
14%
Cell Invasion
14%
Drug Resistance
14%
Cell Motility
14%
Chemistry
Assay
57%
Cell Viability
28%
Chemokine
28%
Procedure
14%
Potential
14%
Resistance
14%